184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study

B Escudier,R Flippot,M Naigeon,M Meylan,Y Vano,S Chouaib,F Tantot,N Chaput-Gras,N Rioux-Leclercq,L Carril Ajuria,C Sautes-Fridman,L Albiges,C Dalban,A Desnoyer,C De Oliveira,B Beuselinck

doi:10.1016/j.iotech.2023.100643

184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study

B Escudier, R Flippot + Show 14 more

Open Access

https://doi.org/10.1016/j.iotech.2023.100643

Copy DOI

Journal: Immuno-Oncology and Technology	Publication Date: Dec 1, 2023
License type: cc-by-nc-nd

#Metastatic Clear Cell Renal Carcinoma #Metastatic Renal Cell Carcinoma Patients + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

184P Elevated baseline circulating IL-8 is associated with increased expression of the IMmotion myeloid gene signature (GS) in metastatic clear cell renal cell carcinoma (mRCC) patients (pts) treated with nivolumab (nivo) within the NIVOREN GETUG-AFU 26 study

Full Text